This inventor holds 1 USPTO granted patent. Top assignee: Bend Research, Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Timothy J McDermott
Introduction
Timothy J McDermott is a notable inventor based in Salem, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms that enhance drug efficacy. His work is characterized by a focus on combining different therapeutic agents to improve patient outcomes.
Latest Patents
Timothy J McDermott holds a patent for "Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor." This innovative dosage form includes a solid amorphous dispersion that comprises a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer. Additionally, it incorporates an HMG-CoA reductase inhibitor, ensuring that these components remain substantially separate within the dosage form. This unique formulation aims to optimize the therapeutic effects of the included drugs.
Career Highlights
Timothy has been associated with Bend Research, Inc., where he has contributed to various projects aimed at advancing pharmaceutical formulations. His expertise in drug delivery systems has positioned him as a valuable asset in the research and development sector.
Collaborations
Some of Timothy's notable coworkers include Dwayne Thomas Friesen and David Keith Lyon. Their collaborative efforts have further enhanced the innovative work being conducted at Bend Research, Inc.
Conclusion
Timothy J McDermott's contributions to pharmaceutical innovations exemplify the importance of combining different therapeutic agents to improve drug efficacy. His patent and work at Bend Research, Inc. highlight his commitment to advancing healthcare solutions.